DIRUI Medical issued a profit warning, expecting a net loss of 22 million to 33 million yuan in the first half of the year

According to the Zhitong Finance APP, DIRUI Medical has released its performance forecast for the first half of 2025, expecting a net loss attributable to shareholders of the listed company of 22 million to 33 million yuan, a shift from profit to loss compared to the same period last year. Reasons for the performance change: Due to the continuous impact of market factors and industry policies, the company's overall gross profit has declined. The international market remains relatively stable, while the domestic market's installation and reagent volume of the company's instrument products have not met expectations, resulting in a significant decrease in the company's net profit level